210 related articles for article (PubMed ID: 21848315)
1. Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147.
Liu W; Chan AS; Liu H; Cochrane SA; Vederas JC
J Am Chem Soc; 2011 Sep; 133(36):14216-9. PubMed ID: 21848315
[TBL] [Abstract][Full Text] [Related]
2. Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2.
Pattabiraman VR; Stymiest JL; Derksen DJ; Martin NI; Vederas JC
Org Lett; 2007 Feb; 9(4):699-702. PubMed ID: 17286377
[TBL] [Abstract][Full Text] [Related]
3. A concise stereoselective synthesis of orthogonally protected lanthionine and beta-methyllanthionine.
Cobb SL; Vederas JC
Org Biomol Chem; 2007 Apr; 5(7):1031-8. PubMed ID: 17377656
[TBL] [Abstract][Full Text] [Related]
4. Chemical synthesis of the lantibiotic lacticin 481 reveals the importance of lanthionine stereochemistry.
Knerr PJ; van der Donk WA
J Am Chem Soc; 2013 May; 135(19):7094-7. PubMed ID: 23621626
[TBL] [Abstract][Full Text] [Related]
5. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen.
Liu H; Pattabiraman VR; Vederas JC
Org Lett; 2009 Dec; 11(24):5574-7. PubMed ID: 19921853
[TBL] [Abstract][Full Text] [Related]
7. Structural characterization of the highly cyclized lantibiotic paenicidin A via a partial desulfurization/reduction strategy.
Lohans CT; Huang Z; van Belkum MJ; Giroud M; Sit CS; Steels EM; Zheng J; Whittal RM; McMullen LM; Vederas JC
J Am Chem Soc; 2012 Dec; 134(48):19540-3. PubMed ID: 23167271
[TBL] [Abstract][Full Text] [Related]
8. The importance of the leader sequence for directing lanthionine formation in lacticin 481.
Patton GC; Paul M; Cooper LE; Chatterjee C; van der Donk WA
Biochemistry; 2008 Jul; 47(28):7342-51. PubMed ID: 18570437
[TBL] [Abstract][Full Text] [Related]
9. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates.
Sit CS; Yoganathan S; Vederas JC
Acc Chem Res; 2011 Apr; 44(4):261-8. PubMed ID: 21366289
[TBL] [Abstract][Full Text] [Related]
11. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
12. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of Nonproteinogenic Amino Acids in Class I and II Lantibiotics.
Kakkar N; Perez JG; Liu WR; Jewett MC; van der Donk WA
ACS Chem Biol; 2018 Apr; 13(4):951-957. PubMed ID: 29439566
[TBL] [Abstract][Full Text] [Related]
14. In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids.
Levengood MR; Knerr PJ; Oman TJ; van der Donk WA
J Am Chem Soc; 2009 Sep; 131(34):12024-5. PubMed ID: 19655738
[TBL] [Abstract][Full Text] [Related]
15. Lantibiotics: insight and foresight for new paradigm.
Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
[TBL] [Abstract][Full Text] [Related]
16. Structure and biosynthesis of carnolysin, a homologue of enterococcal cytolysin with D-amino acids.
Lohans CT; Li JL; Vederas JC
J Am Chem Soc; 2014 Sep; 136(38):13150-3. PubMed ID: 25207953
[TBL] [Abstract][Full Text] [Related]
17. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
18. Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.
Knerr PJ; van der Donk WA
J Am Chem Soc; 2012 May; 134(18):7648-51. PubMed ID: 22524291
[TBL] [Abstract][Full Text] [Related]
19. A system for the random mutagenesis of the two-peptide lantibiotic lacticin 3147: analysis of mutants producing reduced antibacterial activities.
Field D; Collins B; Cotter PD; Hill C; Ross RP
J Mol Microbiol Biotechnol; 2007; 13(4):226-34. PubMed ID: 17827973
[TBL] [Abstract][Full Text] [Related]
20. Solid-supported synthesis and biological evaluation of the lantibiotic peptide bis(desmethyl) lacticin 3147 A2.
Pattabiraman VR; McKinnie SM; Vederas JC
Angew Chem Int Ed Engl; 2008; 47(49):9472-5. PubMed ID: 18937239
[No Abstract] [Full Text] [Related]
[Next] [New Search]
